HNRNPC and breast carcinoma: HNRNPC is thought to be a prognostic marker in tumors [35] and has been demonstrated to be highly expressed in multiple tumors, including hepatocellular carcinoma [36], breast cancer [37], glioblastoma [38], and ovarian cancer [39].